Table of Content

1. Preface

1.1. Market Definition and Scope

1.2. Market Segmentation

1.3. Key Research Objectives

1.4. Research Highlights


2. Assumptions and Research Methodology


3. Executive Summary: Global Photodynamic Therapy Market


4. Market Overview

4.1. Introduction

4.2. Overview

4.3. Market Dynamics

4.3.1. Drivers

4.3.2. Restraints

4.3.3. Opportunities

4.4. Global Photodynamic Therapy Market Analysis and Forecast, 2017–2027


5. Market Outlook

5.1. Epidemiology of Skin Disorders and Cancer

5.2. Major Companies in Global Photodynamic Therapy Market

5.3. Regulatory Scenario Assessment

5.4. Technological Advancements

5.5. Major Diseases Treated through Photodynamic Therapy

5.6. Patent Landscape Summary


6. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product

6.1. Introduction & Definition

6.2. Global Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

6.2.1. Drugs

6.2.1.1. Porphyrin Derivative (PD)

6.2.1.1.1. Hematoporphyrin Derivative (HpD)

6.2.1.1.2. Benzoporphyrin Derivative (BPD)

6.2.1.1.3. Texaphyrins

6.2.1.1.4. Others

6.2.1.2. Aminolevulinic acid (ALA)

6.2.1.3. Chlorines

6.2.1.4. Others

6.2.2. Devices

6.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

6.2.2.2. Diode Laser

6.3. Global Photodynamic Therapy Market Attractiveness, by Product


7. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application

7.1. Introduction

7.2. Global Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

7.2.1. Cancer

7.2.1.1. Basal Cell Carcinoma

7.2.1.2. Non-small Cell Lung Cancer

7.2.1.3. Head & Neck Cancer

7.2.1.4. Others

7.2.2. Actinic Keratosis (AK)

7.2.3. Psoriasis

7.2.4. Acne

7.2.5. Others

7.3. Global Photodynamic Therapy Market Attractiveness, by Application


8. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user

8.1. Introduction

8.2. Global Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

8.2.1. Hospitals

8.2.2. Cosmetics & Dermatology Clinics

8.2.3. Cancer Treatment Centers

8.2.4. Others

8.3. Global Photodynamic Therapy Market Attractiveness, by End-user


9. Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region

9.1. Introduction

9.2. Global Photodynamic Therapy Market Value Forecast, by Region, 2017–2027

9.2.1. North America

9.2.2. Europe

9.2.3. Asia Pacific

9.2.4. Latin America

9.2.5. Middle East & Africa

9.3. Global Photodynamic Therapy Market Attractiveness, by Region


10. North America Photodynamic Therapy Market Analysis and Forecast

10.1. Introduction

10.2. North America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

10.2.1. Drugs

10.2.1.1. Porphyrin Derivative (PD)

10.2.1.1.1. Hematoporphyrin Derivative (HpD)

10.2.1.1.2. Benzoporphyrin Derivative (BPD)

10.2.1.1.3. Texaphyrins

10.2.1.1.4. Others

10.2.1.2. Aminolevulinic Acid (ALA)

10.2.1.3. Chlorines

10.2.1.4. Others

10.2.2. Devices

10.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

10.2.2.2. Diode Laser

10.3. North America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

10.3.1. Cancer

10.3.1.1. Basal Cell Carcinoma

10.3.1.2. Non-small Cell Lung Cancer

10.3.1.3. Head & Neck Cancer

10.3.1.4. Others

10.3.2. Actinic Keratosis (AK)

10.3.3. Psoriasis

10.3.4. Acne

10.3.5. Others

10.4. North America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

10.4.1. Hospitals

10.4.2. Cosmetics & Dermatology Clinics

10.4.3. Cancer Treatment Centers

10.4.4. Others

10.5. North America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

10.5.1. U.S.

10.5.2. Canada

10.6. North America Photodynamic Therapy Market Attractiveness Analysis

10.6.1. By Product

10.6.2. By Application

10.6.3. By End-user

10.6.4. By Country


11. Europe Photodynamic Therapy Market Analysis and Forecast

11.1. Introduction

11.2. Europe Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

11.2.1. Drugs

11.2.1.1. Porphyrin Derivative (PD)

11.2.1.1.1. Hematoporphyrin Derivative (HpD)

11.2.1.1.2. Benzoporphyrin Derivative (BPD)

11.2.1.1.3. Texaphyrins

11.2.1.1.4. Others

11.2.1.2. Aminolevulinic Acid (ALA)

11.2.1.3. Chlorines

11.2.1.4. Others

11.2.2. Devices

11.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

11.2.2.2. Diode Laser

11.3. Europe Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

11.3.1. Cancer

11.3.1.1. Basal Cell Carcinoma

11.3.1.2. Non-small Cell Lung Cancer

11.3.1.3. Head & Neck Cancer

11.3.1.4. Others

11.3.2. Actinic Keratosis (AK)

11.3.3. Psoriasis

11.3.4. Acne

11.3.5. Others

11.4. Europe Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

11.4.1. Hospitals

11.4.2. Cosmetics & Dermatology Clinics

11.4.3. Cancer Treatment Centers

11.4.4. Others

11.5. Europe Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

11.5.1. Germany

11.5.2. U.K.

11.5.3. France

11.5.4. Spain

11.5.5. Italy

11.5.6. Rest of Europe

11.6. Europe Photodynamic Therapy Market Attractiveness Analysis

11.6.1. By Product

11.6.2. By Application

11.6.3. By End-user

11.6.4. By Country/Sub-region

12. Asia Pacific Photodynamic Therapy Market Analysis and Forecast

12.1. Introduction

12.2. Asia Pacific Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

12.2.1. Drugs

12.2.1.1. Porphyrin Derivative (PD)

12.2.1.1.1. Hematoporphyrin Derivative (HpD)

12.2.1.1.2. Benzoporphyrin Derivative (BPD)

12.2.1.1.3. Texaphyrins

12.2.1.1.4. Others

12.2.1.2. Aminolevulinic Acid (ALA)

12.2.1.3. Chlorines

12.2.1.4. Others

12.2.2. Devices

12.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

12.2.2.2. Diode Laser

12.3. Asia Pacific Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

12.3.1. Cancer

12.3.1.1. Basal Cell Carcinoma

12.3.1.2. Non-small Cell Lung Cancer

12.3.1.3. Head & Neck Cancer

12.3.1.4. Others

12.3.2. Actinic Keratosis (AK)

12.3.3. Psoriasis

12.3.4. Acne

12.3.5. Others

12.4. Asia Pacific Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

12.4.1. Hospitals

12.4.2. Cosmetics & Dermatology Clinics

12.4.3. Cancer Treatment Centers

12.4.4. Others

12.5. Asia Pacific Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

12.5.1. Japan

12.5.2. China

12.5.3. India

12.5.4. Australia & New Zealand

12.5.5. Rest of Asia Pacific

12.6. Asia Pacific Photodynamic Therapy Market Attractiveness Analysis

12.6.1. By Product

12.6.2. By Application

12.6.3. By End-user

12.6.4. By Country/Sub-region

13. Latin America Photodynamic Therapy Market Analysis and Forecast

13.1. Introduction

13.2. Latin America Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

13.2.1. Drugs

13.2.1.1. Porphyrin Derivative (PD)

13.2.1.1.1. Hematoporphyrin Derivative (HpD)

13.2.1.1.2. Benzoporphyrin Derivative (BPD)

13.2.1.1.3. Texaphyrins

13.2.1.1.4. Others

13.2.1.2. Aminolevulinic Acid (ALA)

13.2.1.3. Chlorines

13.2.1.4. Others

13.2.2. Devices

13.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

13.2.2.2. Diode Laser

13.3. Latin America Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

13.3.1. Cancer

13.3.1.1. Basal Cell Carcinoma

13.3.1.2. Non-small Cell Lung Cancer

13.3.1.3. Head & Neck Cancer

13.3.1.4. Others

13.3.2. Actinic Keratosis (AK)

13.3.3. Psoriasis

13.3.4. Acne

13.3.5. Others

13.4. Latin America Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

13.4.1. Hospitals

13.4.2. Cosmetics & Dermatology Clinics

13.4.3. Cancer Treatment Centers

13.4.4. Others

13.5. Latin America Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

13.5.1. Brazil

13.5.2. Mexico

13.5.3. Rest of Latin America

13.6. Latin America Photodynamic Therapy Market Attractiveness Analysis

13.6.1. By Product

13.6.2. By Application

13.6.3. By End-user

13.6.4. By Country/Sub-region


14. Middle East & Africa Photodynamic Therapy Market Analysis and Forecast

14.1. Introduction

14.2. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Product, 2017–2027

14.2.1. Drugs

14.2.1.1. Porphyrin Derivative (PD)

14.2.1.1.1. Hematoporphyrin Derivative (HpD)

14.2.1.1.2. Benzoporphyrin Derivative (BPD)

14.2.1.1.3. Texaphyrins

14.2.1.1.4. Others

14.2.1.2. Aminolevulinic Acid (ALA)

14.2.1.3. Chlorines

14.2.1.4. Others

14.2.2. Devices

14.2.2.1. Disposable Fiber Optic Light Delivery Devices (DFOLDD)

14.2.2.2. Diode Laser

14.3. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Application, 2017–2027

14.3.1. Cancer

14.3.1.1. Basal Cell Carcinoma

14.3.1.2. Non-small Cell Lung Cancer

14.3.1.3. Head & Neck Cancer

14.3.1.4. Others

14.3.2. Actinic Keratosis (AK)

14.3.3. Psoriasis

14.3.4. Acne

14.3.5. Others

14.4. Middle East & Africa Photodynamic Therapy Market Value Forecast, by End-user, 2017–2027

14.4.1. Hospitals

14.4.2. Cosmetics & Dermatology Clinics

14.4.3. Cancer Treatment Centers

14.4.4. Others

14.5. Middle East & Africa Photodynamic Therapy Market Value Forecast, by Country/Sub-region, 2017–2027

14.5.1. GCC Countries

14.5.2. South Africa

14.5.3. Rest of Middle East & Africa

14.6. Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis

14.6.1. By Product

14.6.2. By Application

14.6.3. By End-user

14.6.4. By Country/Sub-region


15. Competition Landscape

15.1. Global Photodynamic Therapy Market Share Analysis, by Company (2018)

15.2. Company Profiles

15.2.1. Biofrontera AG

15.2.1.1. Company Description

15.2.1.2. Business Overview

15.2.1.3. Financial Overview

15.2.1.4. Strategic Overview

15.2.1.5. SWOT Analysis

15.2.2. Theralase Technologies Inc.

15.2.2.1. Company Description

15.2.2.2. Business Overview

15.2.2.3. Financial Overview

15.2.2.4. Strategic Overview

15.2.2.5. SWOT Analysis

15.2.3. LUMIBIRD

15.2.3.1. Company Description

15.2.3.2. Business Overview

15.2.3.3. SWOT Analysis

15.2.4. Quest PharmaTech Inc.

15.2.4.1. Company Description

15.2.4.2. Business Overview

15.2.4.3. Financial Overview

15.2.4.4. Strategic Overview

15.2.4.5. SWOT Analysis

15.2.5. Modulight, Inc.

15.2.5.1. Company Description

15.2.5.2. Business Overview

15.2.5.3. Strategic Overview

15.2.5.4. SWOT Analysis

15.2.6. Galderma Laboratories L.P. (Nestl?)

15.2.6.1. Company Description

15.2.6.2. Business Overview

15.2.6.3. Financial Overview

15.2.6.4. Strategic Overview

15.2.6.5. SWOT Analysis

15.2.7. Sun Pharmaceutical Industries Ltd.

15.2.7.1. Company Description

15.2.7.2. Business Overview

15.2.7.3. Financial Overview

15.2.7.4. Strategic Overview

15.2.7.5. SWOT Analysis

15.2.8. SUS Advancing Technology Co., Ltd

15.2.8.1. Company Description

15.2.8.2. Business Overview

15.2.8.3. SWOT Analysis



List of Figures



Figure 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, 2017–2027

Figure 02: Global Photodynamic Therapy Market Value Share (%), by Product, 2018

Figure 03: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2018

Figure 04: Global Photodynamic Therapy Market Value Share (%), by Application, 2018

Figure 05: Global Photodynamic Therapy Market Value Share (%), by Region, 2018

Figure 06: Global Photodynamic Therapy Market Value Share (%), by Product, 2018 and 2027

Figure 07: Global Photodynamic Therapy Market Value Share (%), by Drugs, 2018 and 2027

Figure 08: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drugs, 2017–2027

Figure 09: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Devices, 2017–2027

Figure 10: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Porphyrin Derivative (PD), 2017–2027

Figure 11: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aminolevulinic Acid (ALA), 2017–2027

Figure 12: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Chlorines, 2017–2027

Figure 13: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 14: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by DFOLDD, 2017–2027

Figure 15: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diode Laser, 2017–2027

Figure 16: Global Photodynamic Therapy Market Attractiveness, by Product, 2019–2027

Figure 17: Global Photodynamic Therapy Market Attractiveness, by Drugs, 2019–2027

Figure 18: Global Photodynamic Therapy Market Attractiveness, by Devices, 2019–2027

Figure 19: Global Photodynamic Therapy Market Value Share (%), by Application, 2018 and 2027

Figure 20: Global Photodynamic Therapy Market Attractiveness, by Application, 2019–2027

Figure 21: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer, 2017–2027

Figure 22: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Actinic Keratosis (AK), 2017–2027

Figure 23: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Psoriasis, 2017–2027

Figure 24: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Acne, 2017–2027

Figure 25: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 26: Global Photodynamic Therapy Market Value Share (%), by End-user, 2018 and 2027

Figure 27: Global Photodynamic Therapy Market Attractiveness Analysis, by End-user

Figure 28: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 29: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics & Dermatology Clinics, 2017–2027

Figure 30: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cancer Treatment Centers, 2017–2027

Figure 31: Global Photodynamic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 32: Global Photodynamic Therapy Market Value Share Analysis, by Region, 2018 and 2027

Figure 33: Global Photodynamic Therapy Market Attractiveness Analysis, by Region, 2019-2027

Figure 34: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 35: North America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 36: North America Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 37: North America Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 38: North America Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 39: North America Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 40: North America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 41: North America Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 42: North America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 43: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 44: Europe Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 45: Europe Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 46: Europe Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 47: Europe Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 48: Europe Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 49: Europe Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 50: Europe Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 51: Europe Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 52: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 53: Asia Pacific Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 54: Asia Pacific Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 55: Asia Pacific Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 56: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 57: Asia Pacific Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 58: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 59: Asia Pacific Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 60: Asia Pacific Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 61: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 62: Latin America Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 63: Latin America Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 64: Latin America Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 65: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 66: Latin America Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 67: Latin America Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 68: Latin America Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 69: Latin America Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027

Figure 70: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017-2027

Figure 71: Middle East & Africa Photodynamic Therapy Market Value Share (%), by Country/Sub-region, 2018 and 2027

Figure 72: Middle East & Africa Photodynamic Therapy Market Attractiveness, by Country/Sub-region, 2019–2027

Figure 73: Middle East & Africa Photodynamic Therapy Market Value Share, by Product, 2018 and 2027

Figure 74: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Product, 2019–2027

Figure 75: Middle East & Africa Photodynamic Therapy Market Value Share, by Application, 2018 and 2027

Figure 76: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by Application, 2019–2027

Figure 77: Middle East & Africa Photodynamic Therapy Market Value Share, by End-user, 2018 and 2027

Figure 78: Middle East & Africa Photodynamic Therapy Market Attractiveness Analysis, by End-user, 2019–2027


List of Tables


List of Tables

Table 01: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 02: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 03: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 04: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 05: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 06: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 07: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 08: Global Photodynamic Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 09: North America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 10: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 11: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 12: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 13: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 14: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 15: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 16: North America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 17: Europe Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 18: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 19: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drug, 2017–2027

Table 20: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 21: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 22: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 23: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 24: Europe Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 25: Asia Pacific Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 26: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 27: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 28: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 29: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 30: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 31: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 32: Asia Pacific Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 33: Latin America Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 34: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 35: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 36: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 37: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 38: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 39: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 40: Latin America Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 41: Middle East & Africa Photodynamic Therapy Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 42: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Product, 2017–2027

Table 43: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Drugs, 2017–2027

Table 44: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Porphyrin Derivative (PD), 2017–2027

Table 45: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Devices, 2017–2027

Table 46: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 47: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by Cancer, 2017–2027

Table 48: Middle East & Africa Photodynamic Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2027